We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

117 hedge funds and large institutions have $264M invested in BioSpecifics Technologies Corp. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

9% more funds holding

Funds holding: 107 → 117 (+10)

1% more capital invested

Capital invested by funds: $263M → $264M (+$1.54M)

16% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 43

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
117
Holders Change
+10
Holders Change %
+9.35%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
36
Reduced
43
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$4.28M
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.25M
3
MCM
Matarin Capital Management
New York
+$2.84M
4
Deutsche Bank
Deutsche Bank
Germany
+$2.55M
5
CCMG
Clark Capital Management Group
Pennsylvania
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$13.2M
2
BlackRock
BlackRock
New York
-$7.17M
3
ECP
Elk Creek Partners
Colorado
-$2.11M
4
Goldman Sachs
Goldman Sachs
New York
-$1.96M
5
EP
Eversept Partners
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
51
Hillsdale Investment Management
Ontario, Canada
$661K +$173K +2,620 +33%
JP Morgan Chase
52
JP Morgan Chase
New York
$653K +$407K +6,152 +143%
IP
53
Isthmus Partners
Wisconsin
$648K -$1.28M -19,379 -92%
DCM
54
Dupont Capital Management
Delaware
$621K – – –
Swiss National Bank
55
Swiss National Bank
Switzerland
$605K – – –
SO
56
STRS Ohio
Ohio
$585K – – –
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$585K +$184K +2,784 +42%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$553K -$33.3K -504 -5%
CIBC Private Wealth Group
59
CIBC Private Wealth Group
Georgia
$545K +$8.86K +134 +2%
UBS Group
60
UBS Group
Switzerland
$535K +$318K +4,800 +127%
Two Sigma Advisers
61
Two Sigma Advisers
New York
$511K -$271K -4,100 -33%
SAM
62
Shell Asset Management
Netherlands
$502K – – –
CI
63
Cavalier Investments
Georgia
$486K +$205K +3,100 +66%
Squarepoint
64
Squarepoint
New York
$481K -$15.6K -236 -3%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$467K +$106K +1,600 +27%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$455K -$14.8K -224 -3%
GC
67
Globeflex Capital
California
$424K +$66.3K +1,002 +17%
MF
68
Manchester Financial
California
$394K – – –
MPAM
69
Monarch Partners Asset Management
Massachusetts
$392K -$196K -2,960 -32%
AllianceBernstein
70
AllianceBernstein
Tennessee
$380K – – –
AA
71
ALPS Advisors
Colorado
$362K +$385K +5,814 New
ECM
72
Element Capital Management
New York
$341K +$362K +5,476 New
SAM
73
Sawgrass Asset Management
Florida
$336K +$356K +5,385 New
Bank of Montreal
74
Bank of Montreal
Ontario, Canada
$317K -$14.6K -220 -4%
SGAM
75
Smith Group Asset Management
Texas
$313K -$32.7K -495 -9%
1 2
3
4 5

BSTC Hedge Fund Activity: Q1 2019 in Review

117 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2019, worth a combined $264M — up 0.59% from $263M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BSTC positions and 6 closed out — a net gain of 10 holders — while 36 added to existing stakes and 43 trimmed.

The largest buyer was Rice Hall James & Associates, adding an estimated $4.28M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $13.2M sold.

  • 117 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2019, up from 107 in Q4 2018.
  • Funds reported $264M of BioSpecifics Technologies Corp. stock for Q1 2019, up 0.59% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q1 2019 and 6 closed out, a net change of +10 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2019 was Rice Hall James & Associates, an estimated $4.28M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2019 was Stonepine Capital Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q1 2019.